Clinical Trials Browser

Phase 2 × OTHER × Esophageal Squamous Carcinoma × Clear all

NCT07490002 2026-03-24

Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in Resectable ESCC

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Squamous Carcinoma